KBC Group NV Trims Stock Position in Dolby Laboratories $DLB

KBC Group NV cut its stake in Dolby Laboratories (NYSE:DLB) by 47.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,476 shares of the electronics maker’s stock after selling 1,313 shares during the quarter. KBC Group NV’s holdings in Dolby Laboratories were worth $110,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Vise Technologies Inc. purchased a new position in shares of Dolby Laboratories during the second quarter valued at about $276,000. Allworth Financial LP boosted its position in Dolby Laboratories by 590.4% during the 2nd quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock valued at $37,000 after acquiring an additional 431 shares in the last quarter. Acadian Asset Management LLC grew its holdings in shares of Dolby Laboratories by 1.7% during the 2nd quarter. Acadian Asset Management LLC now owns 1,160,661 shares of the electronics maker’s stock worth $86,172,000 after acquiring an additional 19,840 shares during the period. Campbell & CO Investment Adviser LLC grew its holdings in shares of Dolby Laboratories by 193.2% during the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 17,275 shares of the electronics maker’s stock worth $1,283,000 after acquiring an additional 11,384 shares during the period. Finally, AGF Management Ltd. raised its position in shares of Dolby Laboratories by 21.1% in the 2nd quarter. AGF Management Ltd. now owns 39,948 shares of the electronics maker’s stock worth $2,967,000 after acquiring an additional 6,971 shares in the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CEO Kevin J. Yeaman sold 25,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total value of $1,721,750.00. Following the transaction, the chief executive officer directly owned 114,725 shares of the company’s stock, valued at approximately $7,901,110.75. This represents a 17.89% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 38.39% of the stock is currently owned by insiders.

Dolby Laboratories Price Performance

Shares of NYSE:DLB opened at $67.52 on Friday. The business has a fifty day moving average price of $68.59 and a 200-day moving average price of $72.36. The company has a market capitalization of $6.47 billion, a PE ratio of 24.73 and a beta of 0.97. Dolby Laboratories has a 1-year low of $64.02 and a 1-year high of $89.66.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating the consensus estimate of $0.70 by $0.29. The company had revenue of $307.02 million for the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. Dolby Laboratories’s revenue for the quarter was up .7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS. On average, sell-side analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd will be given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 2.1%. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend is Tuesday, December 2nd. Dolby Laboratories’s payout ratio is 54.75%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on DLB. Baird R W upgraded Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Thursday, November 13th. Robert W. Baird initiated coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They issued a “neutral” rating and a $74.00 price target for the company. Finally, Rosenblatt Securities lowered their price target on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Wednesday. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Dolby Laboratories currently has a consensus rating of “Moderate Buy” and an average price target of $92.00.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.